NOMAD Power Solutions, Inc. (NMAD) vs Zhengye Biotechnology Holding Limited (ZYBT)
A side-by-side comparison of NOMAD Power Solutions, Inc. and Zhengye Biotechnology Holding Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NMAD
NOMAD Power Solutions, Inc.
$4.25HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
ZYBT
Zhengye Biotechnology Holding Limited
$1.11HealthcareDelayed quote: Oct 6, 2026, 3:44 PM EDT
Total return — NMAD vs ZYBT
growth of $100 · dividends reinvested · last 1yNMAD -39.7% (-39.7%/yr)ZYBT +37.7% (+37.7%/yr)ZYBT compounded faster over this window
NMAD ZYBT
NMAD vs ZYBT: by the numbers
- •ZYBT is the larger company ($53M vs $53M market cap).
- •Both run net losses; NMAD's is the smaller (0.00% vs -59.97% net margin).
Metrics side by side
Valuation
| Metric | NMAD | ZYBT |
|---|---|---|
| P/B ratio | 2199.36 | 1.47 |
Profitability
| Metric | NMAD | ZYBT |
|---|---|---|
| Gross margin | 0.00% | 20.51% |
| Operating margin | 0.00% | -58.66% |
| Net margin | 0.00% | -59.97% |
| ROE | -36114.03% | -27.93% |
| ROIC | -31665.34% | -17.88% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.